We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Oxford Biomedica has signed a five-year collaboration agreement with the Vaccines Manufacturing and Innovation Center (VMIC) to manufacture viral vector-based vaccines. Read More
The funding also includes a delivery of 10 million doses this year that can be used in phase 2/3 clinical trials or under Emergency Use Authorization. Read More
Inovio Pharmaceuticals has sued its primary vaccine manufacturer VGXI for alleged breach of contract over production of Inovio’s COVID-19 vaccine candidate. Read More
Makers of Zoloft (sertraline hydrochloride) and its generic versions are reporting shortages linked to increased demand during the pandemic coupled with supply chain issues caused by the impact of COVID-19 on manufacturers of active pharmaceutical ingredients (APIs). Read More
The agreement will begin immediately to address Moderna's increasing demand over the upcoming months and will focus on securing future long-term supply. Read More
The agreement builds upon a previous deal that AstraZeneca and the University of Oxford entered into last month, under which the company is responsible for manufacturing the vaccine. Read More